Management of Menopause-Related Symptoms - AHRQ Archive ...

More documents

Recommendations

Info

This document is in the public domain and may be used and reprinted without permission exceptthose copyrighted materials noted for which further reproduction is prohibited without thespecific permission of copyright holders.Suggested citation:Nelson HD, Haney E, Humphrey L, Miller J, Nedrow A, Nicolaidis C, Vesco K, Walker M,Bougatsos C, Nygren P. Management of Menopause-Related Symptoms. EvidenceReport/Technology Assessment No. 120. (Prepared by the Oregon Evidence-based PracticeCenter, under Contract No. 290-02-0024.) AHRQ Publication No. 05-E016-2. Rockville, MD:Agency for Healthcare Research and Quality. March 2005.ii
Page 1: Evidence Report/Technology Assessme
Page 5 and 6: AcknowledgmentsThis systematic evid
Page 8 and 9: FiguresFigure 1. Normal Reproductiv
Page 10 and 11: Conference on Management of Menopau
Page 12 and 13: compared with premenopausal women i
Page 14 and 15: depression, or smoking status. The
Page 17 and 18: Chapter 1. IntroductionPurposeThis
Page 19 and 20: Measures of Menopausal SymptomsAlth
Page 21 and 22: Inclusion and Exclusion CriteriaKey
Page 23 and 24: Chapter 3. ResultsTo address Key Qu
Page 25 and 26: fair, 20,26,28,63 and three poor. 2
Page 27 and 28: affecting 50 percent or more of wom
Page 29 and 30: vasomotor symptoms were less common
Page 31 and 32: Key Question 3. Benefits and Advers
Page 33 and 34: Mood symptoms. Thirteen trials of e
Page 35 and 36: with tibolone, but no differences b
Page 37 and 38: Gabapentin use reduced levels of al
Page 39 and 40: A fair-quality trial comparing gins
Page 41 and 42: urogenital symptoms. Some, but not
Page 43 and 44: Premature Ovarian FailureOnly one t
Page 45 and 46: Summary• Evidence is not availabl
Page 47 and 48: Chapter 4. DiscussionBased on revie
Page 49 and 50: 26. Mitchell ES, Woods NF. Symptom
Page 51 and 52: 75. Hagstad A, Janson PO. The epide
Page 53 and 54:
125. Furuhjelm M, Karlgren E, Carls
Page 55 and 56:
170. Mendoza N, Pison JA, Fernandez
Page 57 and 58:
219. Brzezinski AAHSRRASATVS, et al
Page 59 and 60:
267. Teoman N, Ozcan A, Acar B. The
Page 61 and 62:
22. Anonymous. Clonidine in treatme
Page 63 and 64:
68. Bernhard LA, Sheppard L. Health
Page 65 and 66:
112. Carranza-Lira S, Cortes-Fuente
Page 67 and 68:
158. Davis MC, Matthews KA, Meilahn
Page 69 and 70:
206. Force USPST. Postmenopausal ho
Page 71 and 72:
251. Greenblatt RB, Bruneteau DW. M
Page 73 and 74:
299. Hunter MS. Psychological and s
Page 75 and 76:
345. Kurabayashi T, Okada M, Tanaka
Page 77 and 78:
389. Maheux R, Naud F, Rioux M, et
Page 79 and 80:
434. Obillo E, Eleazar J, Demeterio
Page 81 and 82:
478. Progetto Menopausa Italia Stud
Page 83 and 84:
523. Rymer J, Chapman MG, Fogelman
Page 85 and 86:
571. Simkin-Silverman LR, Wing RR,
Page 87 and 88:
618. Thompson E, Douglas D, Reilly
Page 89 and 90:
665. Weel AE, Uitterlinden AG, West
Page 91 and 92:
Figures
Page 93 and 94:
Figure 2. Analytic frameworkInterve
Page 95 and 96:
Tables
Page 97 and 98:
Table 1. Measures of menopause rela
Page 99 and 100:
Table 2. Descriptions of cohort stu
Page 101 and 102:
Table 3. Results of cohort studies
Page 103 and 104:
Page 105 and 106:
Study, year Cohort Population N Sym
Page 107 and 108:
Study, year Cohort Population N Sym
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Table 4. Results of cross-sectional
Page 117 and 118:
Table 5. Trials of estrogen for dep
Page 119 and 120:
Table 5. Trials of estrogen for dep
Page 121 and 122:
Table 7. Trials of AndrogensStudy,y
Page 123 and 124:
Table 7. Trials of Androgens (conti
Page 125 and 126:
Table 8. Trials of tibolone (contin
Page 127 and 128:
Table 8. Trials of tibolone (contin
Page 129 and 130:
Table 9. Trials of antidepressant d
Page 131 and 132:
Table 10. Trials of ClonidineStudy,
Page 133 and 134:
†Pre-crossover data not reported1
Page 135 and 136:
Table 12. Trials of phytoestrogens
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Table 13. Trials of complementary a
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Table 14. Trials of behavioral inte
Page 149 and 150:
Table 15. Summary of benefits of th
Page 151 and 152:
Table 16. Trials in women with brea
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Appendix A. Technical Expert Panel
Page 159 and 160:
Appendix C. Literature Search Strat
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Appendix D. Inclusion and Exclusion
Page 184 and 185:
Appendix D. Inclusion and Exclusion
Page 186 and 187:
Appendix F: Evidence table 6-1. Key
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
Page 386 and 387:
Page 388 and 389:
Page 390 and 391:
Page 392 and 393:
Page 394 and 395:
Page 396 and 397:
Page 398 and 399:
Page 400 and 401:
Page 402 and 403:
Page 404 and 405:
Page 406 and 407:
Page 408 and 409:
Page 410 and 411:
Page 412 and 413:
Page 414 and 415:
Page 416 and 417:
Page 418 and 419:
Page 420 and 421:
Page 422 and 423:
Page 424 and 425:
Page 426 and 427:
Page 428 and 429:
Page 430 and 431:
Page 432 and 433:
Page 434 and 435:
Page 436 and 437:
Page 438 and 439:
Page 440 and 441:
Page 442 and 443:
Page 444 and 445:
Page 446 and 447:
Page 448 and 449:
Page 450 and 451:
Appendix F. Evidence table 6-1. Key
Page 452 and 453:
Page 454 and 455:
Page 456 and 457:
Page 458 and 459:
Page 460 and 461:
Page 462 and 463:
Page 464 and 465:
Page 466 and 467:
Page 468 and 469:
Page 470 and 471:
Page 472 and 473:
Page 474 and 475:
Page 476 and 477:
Page 478 and 479:
Page 480 and 481:
Page 482 and 483:
Page 484 and 485:
Page 486 and 487:
Page 488 and 489:
Page 490 and 491:
Page 492 and 493:
Page 494 and 495:
Page 496 and 497:
Page 498 and 499:
Page 500 and 501:
Page 502 and 503:
Page 504 and 505:
Page 506 and 507:
Page 508 and 509:
Page 510 and 511:
Page 512 and 513:
Page 514 and 515:
Page 516 and 517:
Page 518 and 519:
Page 520 and 521:
Page 522 and 523:
Page 524 and 525:
Page 526 and 527:
Page 528 and 529:
Page 530 and 531:
Page 532 and 533:
Page 534 and 535:
Page 536 and 537:
Page 538 and 539:
Page 540 and 541:
Page 542 and 543:
Page 544 and 545:
Page 546 and 547:
Page 548 and 549:
Page 550 and 551:
Page 552 and 553:
Page 554 and 555:
Page 556 and 557:
Page 558 and 559:
Page 560 and 561:
Page 562 and 563:
Page 564 and 565:
Page 566 and 567:
Page 568 and 569:
Page 570 and 571:
Page 572 and 573:
Page 574 and 575:
Page 576 and 577:
Page 578 and 579:
Page 580 and 581:
Page 582 and 583:
Page 584 and 585:
Page 586 and 587:
Page 588 and 589:
Page 590 and 591:
Page 592 and 593:
Page 594 and 595:
Page 596 and 597:
Page 598 and 599:
Page 600 and 601:
Page 602 and 603:
Page 604 and 605:
Page 606 and 607:
Page 608 and 609:
Page 610 and 611:
Page 612 and 613:
Page 614 and 615:
Page 616 and 617:
Page 618 and 619:
Page 620 and 621:
Page 622 and 623:
Page 624 and 625:
Page 626 and 627:
Page 628 and 629:
Page 630 and 631:
Page 632 and 633:
Page 634 and 635:
Page 636 and 637:
Page 638 and 639:
Page 640 and 641:
Page 642 and 643:
Page 644 and 645:
Page 646 and 647:
Page 648 and 649:
Page 650 and 651:
Page 652 and 653:
Page 654 and 655:
Page 656 and 657:
Page 658 and 659:
Page 660 and 661:
Page 662 and 663:
Page 664 and 665:
Page 666 and 667:
Page 668 and 669:
Page 670 and 671:
Page 672 and 673:
Page 674 and 675:
Page 676 and 677:
Page 678 and 679:
Page 680 and 681:
Page 682 and 683:
Page 684 and 685:
Page 686 and 687:
Page 688 and 689:
Page 690 and 691:
Page 692 and 693:
Page 694 and 695:
Page 696 and 697:
Page 698 and 699:
Page 700 and 701:
Page 702 and 703:
Page 704 and 705:
Page 706 and 707:
Page 708 and 709:
Page 710 and 711:
Page 712 and 713:
Page 714 and 715:
Page 716 and 717:
Page 718 and 719:
Page 720 and 721:
Page 722 and 723:
Page 724 and 725:
Page 726 and 727:
Page 728 and 729:
Page 730 and 731:
Page 732 and 733:
Page 734 and 735:
Page 736 and 737:
Page 738 and 739:
Page 740 and 741:
Page 742 and 743:
Page 744 and 745:
Page 746 and 747:
Page 748 and 749:
Page 750 and 751:
Page 752 and 753:
Page 754 and 755:
Page 756 and 757:
Page 758 and 759:
Page 760 and 761:
Page 762 and 763:
Page 764 and 765:
Page 766 and 767:
Page 768 and 769:
Page 770 and 771:
Page 772 and 773:
Page 774 and 775:
Page 776 and 777:
Page 778 and 779:
Page 780 and 781:
Page 782 and 783:
Page 784 and 785:
Page 786 and 787:
Page 788 and 789:
Page 790 and 791:
Page 792 and 793:
Page 794 and 795:
Page 796 and 797:
Page 798 and 799:
Page 800 and 801:
Page 802 and 803:
Page 804 and 805:
Page 806 and 807:
Page 808 and 809:
Page 810 and 811:
Page 812 and 813:
Page 814 and 815:
Page 816 and 817:
Page 818 and 819:
Page 820 and 821:
Page 822 and 823:
Page 824 and 825:
Page 826 and 827:
Page 828 and 829:
Page 830 and 831:
Page 832 and 833:
Page 834 and 835:
Page 836 and 837:
Page 838 and 839:
Page 840 and 841:
Page 842 and 843:
Page 844 and 845:
Page 846 and 847:
Page 848 and 849:
Page 850 and 851:
Page 852 and 853:
Page 854 and 855:
Page 856 and 857:
Page 858 and 859:
Page 860 and 861:
Page 862 and 863:
Page 864 and 865:
Page 866 and 867:
Page 868 and 869:
Page 870 and 871:
Page 872 and 873:
Page 874 and 875:
Page 876 and 877:
Page 878 and 879:
Page 880 and 881:
Page 882 and 883:
Page 884 and 885:
Page 886 and 887:
Page 888 and 889:
Page 890 and 891:
Page 892 and 893:
Page 894 and 895:
Page 896 and 897:
Page 898 and 899:
Page 900 and 901:
Page 902 and 903:
Page 904 and 905:
Page 906 and 907:
Page 908 and 909:
Page 910 and 911:
Page 912 and 913:
Page 914 and 915:
Page 916:
show all

Management of Menopause-Related Symptoms - AHRQ Archive ...

Create successful ePaper yourself

Delete template?

Save as template?